• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA AORTIC BIOPROSTHESIS; HEART-VALVE, REPLACEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA AORTIC BIOPROSTHESIS; HEART-VALVE, REPLACEMENT Back to Search Results
Model Number 3000TFX
Device Problems Inadequacy of Device Shape and/or Size (1583); Appropriate Term/Code Not Available (3191)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); No Known Impact Or Consequence To Patient (2692)
Event Date 04/14/2020
Event Type  Injury  
Manufacturer Narrative
Patient prosthesis mismatch (ppm) is present when the effective orifice area of the inserted prosthetic valve is too small in relation to body size.Its main hemodynamic consequence is to generate higher than expected gradients through a normally functioning prosthetic valve.Ppm has been shown to be associated with worse hemodynamic function, less regression of left ventricular hypertrophy, more cardiac events, and lower survival.The device was not returned for evaluation, as it remains implanted.The root cause of this event cannot be conclusively determined.However, it is likely that patient related and/or procedural factors contributed to the event.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was reported that a 21mm pericardial aortic valve was disabled via a valve-in-valve procedure after an implant duration of 11 years, 3 months due to patient prothesis mismatch, severe stenosis and mild to moderate regurgitation.A 23mm transcatheter valve was implanted.Patient was discharged home in stable condition on pod #1.  as reported, the surgical valve performed as intended.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA AORTIC BIOPROSTHESIS
Type of Device
HEART-VALVE, REPLACEMENT
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key10038707
MDR Text Key190630595
Report Number2015691-2020-11811
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
PMA/PMN Number
P860057/S022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 04/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/24/2010
Device Model Number3000TFX
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
-
-